Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer
Norihide Kozakai(Keio University Hospital), Mototsugu Oya(Keio University)
Cited by 32
Related Papers
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer
|Journal for ImmunoTherapy of Cancer|2022|65
Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer
|BMC Cancer|2015|45
Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer
|Oncotarget|2017|45
Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer
|American Journal Of Pathology|2012|41
TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells
|Laboratory Investigation|2019|37